Report #2836497

Overview

Sex

Female

Age

Age unknown

State

NY

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

A 60 years old female patient received a dose of Priorix via IM instead of subcutaneous.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 60-year-old female patient who received MMR (Priorix) (batch number 955E2, expiry date 13-SEP-2026) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: A 60 years old female patient received a dose of Priorix via IM instead of subcutaneous.). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-APR-2025 The reporter called to report that a patient received Priorix IM instead of SQ and asked if it was ok, which led to subcutaneous injection formulation administered by other route. The reporter consented to follow up.